Stocktoria
Akso Health Group AHG
Nasdaq · XNAS · stock · Services-Business Services, NEC · website · IPO 2017-11-03
Akso Health Group financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $14.8M | $2.4M | $13.2M | $6.3M | $1.8M |
| Gross profit | -$281,526 | $122,132 | $1.3M | $605,134 | $1.8M |
| R&D expense | — | — | — | $421,186 | $441,405 |
| SG&A expense | $3.6M | $8.6M | — | — | — |
| Operating income | -$166.3M | -$8.6M | -$14.3M | -$3.3M | -$4.2M |
| Interest expense | — | — | — | $804,138 | $2.2M |
| Income tax | -$30.8M | $24,988 | $17,549 | $92,816 | $482,976 |
| Net income | -$135.0M | -$9.5M | -$1.4M | -$16.9M | -$34.8M |
| EPS (diluted) | $-0.16 | $-0.07 | $-0.02 | $-0.28 | $-0.71 |
| Operating cash flow | $1.2M | $1.4M | -$6.0M | -$11.3M | $10.1M |
| Free cash flow | $1.0M | — | — | — | — |
| Cash & equivalents | $176.2M | $85.2M | $7.9M | $18.4M | $15.1M |
| Inventory | $190,242 | $191,201 | $1.7M | $7.8M | — |
| Total assets | $215.0M | $142.0M | $20.5M | $62.8M | $31.7M |
| Total liabilities | $15.8M | $3.6M | $11.6M | $50.5M | $14.4M |
| Shareholders' equity | $199.2M | $138.4M | $8.8M | $12.3M | $17.3M |
Source: SEC EDGAR filings · CIK 0001702318 · as of 2025-03-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.